Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA

Open Biology

Volumn 2, Issue JUNE, 2012, Pages

  Lo, Yuk Ming Dennis ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Down syndrome; Foetal DNA in maternal plasma; Next generation sequencing; Plasma nucleic acids; Trisomy 21

Indexed keywords

DNA;

ANEUPLOIDY; ARTICLE; BLOOD; DOWN SYNDROME; FEMALE; FETUS; FOETAL DNA IN MATERNAL PLASMA; GENETICS; HUMAN; METABOLISM; METHODOLOGY; NEXT-GENERATION SEQUENCING; NUCLEOTIDE SEQUENCE; PLASMA NUCLEIC ACIDS; PREGNANCY; PRENATAL DIAGNOSIS; TRISOMY 21;

DOWN SYNDROME; FOETAL DNA IN MATERNAL PLASMA; NEXT-GENERATION SEQUENCING; PLASMA NUCLEIC ACIDS; TRISOMY 21;

ANEUPLOIDY; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; FETUS; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84864199013     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.120086     Document Type: Article

References (52)

1. Evans MI, Wapner RJ. 2005 Invasive prenatal diagnostic procedures 2005. Semin. Perinatol. 29, 215-218. (doi:10.1053/j.semperi.2005.06.004) (Pubitemid 41133560)
2. Malone FD et al. 2005 First-trimester or secondtrimester screening, or both, for Down's syndrome. N. Engl. J. Med. 353, 2001-2011. (doi:10.1056/ NEJMoa043693) (Pubitemid 41609093)
3. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP. 1997 PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am. J. Hum. Genet. 61, 822-829. (doi:10.1086/514885) (Pubitemid 27418456)
4. Bianchi DW et al. 2002 Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat. Diagn. 22, 609-615. (doi:10. 1002/pd.347) (Pubitemid 34839302)
5. Chen XQ, Stroun M, Magnenat J-L, Nicod LP, Kurt A-M, Lyautey J, Lederrey C, Anker P, 1996 Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat. Med. 2, 1033-1035. (doi:10.1038/nm0996-1033) (Pubitemid 26306844)
6. Nawroz H, Koch W, Anker P, Stroun M, Sidransky D. 1996 Microsatellite alterations in serum DNA of head and neck cancer patients. Nat. Med. 2, 1035-1037. (doi:10.1038/nm0996-1035) (Pubitemid 26306845)
7. Lo YMD, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CWG, Wainscoat JS 1997 Presence of fetal DNA in maternal plasma and serum. Lancet 350, 485-487. (doi:10.1016/S0140-6736(97)02174-0) (Pubitemid 27343304)
8. Lo YMD et al. 1998 Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet. 62, 768-775. (doi:10.1086/301800) (Pubitemid 28194317)
9. Lun FMF, Chiu RWK, Chan KCA, Leung TY, Lau TK, Lo YMD. 2008 Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin. Chem. 54, 1664-1672. (doi:10.1373/clinchem.2008.111385)
10. Lo YMD, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. 1999 Rapid clearance of fetal DNA from maternal plasma. Am. J. Hum. Genet. 64, 218-224. (doi:10.1086/302205) (Pubitemid 30428975)
11. Smid M et al. 2003 No evidence of fetal DNA persistence in maternal plasma after pregnancy. Hum. Genet. 112, 617-618. (Pubitemid 36869057)
12. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. 1996 Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl Acad. Sci. USA 93, 705-708. (doi:10.1073/pnas.93.2.705) (Pubitemid 26041153)
13. Devaney SA, Palomaki GE, Scott JA, Bianchi DW. 2011 Noninvasive fetal sex determination using cellfree fetal DNA: a systematic review and metaanalysis. JAMA 306, 627-636. (doi:10.1001/jama. 2011.1114)
14. Lo YMD, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PMK, Redman CWG, Wainscoat JS. 1998 Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma. N. Engl. J. Med. 339, 1734-1738. (doi:10.1056/NEJM199812103392402) (Pubitemid 28555431)
15. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. 2008 Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. Br. Med. J. 336, 816-818. (doi:10.1136/bmj.39518. 463206.25) (Pubitemid 351548224)
16. Poon LLM, Leung TN, Lau TK, Chow KC, Lo YMD. 2002 Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin. Chem. 48, 35-41. (Pubitemid 34038120)
17. Chim SSC et al. 2005 Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl Acad. Sci. USA 102, 14 753-14 758. (doi:10.1073/pnas.0503335102) (Pubitemid 41457128)
18. Tong YK et al. 2006 Noninvasive prenatal detection of fetal trisomy 18 by epigenetic allelic ratio analysis in maternal plasma: theoretical and empirical considerations. Clin. Chem. 52, 2194-2202. (doi:10.1373/clinchem.2006.076851) (Pubitemid 44924992)
19. Papageorgiou EA, Karagrigoriou A, Tsaliki E, Velissariou V, Carter NP, Patsalis PC. 2011 Fetalspecific DNA methylation ratio permits noninvasive prenatal diagnosis of trisomy 21. Nat. Med. 17, 510-513. (doi:10.1038/nm.2312)
20. Lo YMD et al. 2007 Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat. Med. 13, 218-223. (doi:10.1038/nm1530)
21. Chan KCA et al. 2004 Size distributions of maternal and fetal DNA in maternal plasma. Clin. Chem. 50, 88-92. (doi:10.1373/clinchem.2003.024893) (Pubitemid 38125703)
22. Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. 2004 Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem. 50, 1002-1011. (doi:10.1373/ clinchem.2003.029835) (Pubitemid 38725787)
23. Dhallan R et al. 2004 Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA 291, 1114-1119. (doi:10.1001/jama.291.9.1114) (Pubitemid 38541689)
24. Dhallan R et al. 2007 A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet 369, 474-481. (doi:10.1016/S0140-6736(07) 60115-9) (Pubitemid 46217810)
25. Chung GT, Chiu RWK, Chan KCA, Lau TK, Leung TN, Lo YMD. 2005 Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin. Chem. 51, 655-658. (doi:10. 1373/clinchem.2004.042168) (Pubitemid 40300249)
26. Chinnapapagari SK, Holzgreve W, Lapaire O, Zimmermann B, Hahn S. 2005 Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin. Chem. 51, 652-655. (doi:10.1373/ clinchem.2004.042119) (Pubitemid 40300248)
27. Lo YMD et al. 2007 Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc. Natl Acad. Sci. USA 104, 13 116-13 121. (doi:10. 1073/pnas.0705765104) (Pubitemid 351737602)
28. Fan HC, Quake SR. 2007 Detection of aneuploidy with digital polymerase chain reaction. Anal. Chem. 79, 7576-7579. (doi:10.1021/ac0709394) (Pubitemid 47606128)
29. Schuster SC. 2008 Next-generation sequencing transforms today's biology. Nat. Meth. 5, 16-18. (doi:10.1038/nmeth1156)
30. Chiu RWK et al. 2008 Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc. Natl Acad. Sci. USA 105, 20 458-20 463. (doi:10.1073/pnas.0810641105)
31. Fan HC, Blumenfeld YJ, Chitkara U, Hudgins L, Quake SR. 2008 Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc. Natl Acad. Sci. USA 105, 16 266-16 271. (doi:10.1073/pnas.0808319105)
32. Chiu RWK, Sun H, Akolekar R, Clouser C, Lee C, McKernan K, Zhou D, Nicolaides KH, Lo YMD 2010 Maternal plasma DNA analysis with massively parallel sequencing by ligation for noninvasive prenatal diagnosis of trisomy 21. Clin. Chem. 56, 459-463. (doi:10.1373/clinchem.2009.136507)
33. Lun FMF, Jin YY, Sun H, Leung TY, Lau TK, Chiu RWK, Lo YMD 2011 Noninvasive prenatal diagnosis of a case of Down syndrome due to robertsonian translocation by massively parallel sequencing of maternal plasma DNA. Clin. Chem. 57, 917-919. (doi:10.1373/clinchem.2011.161844)
34. Chiu RWK et al. 2011 Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. Br. Med. J. 342, c7401. (doi:10. 1136/bmj.c7401)
35. Ehrich M et al. 2011 Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am. J. Obstet. Gynecol. 204, 205 e1-e11.
36. Palomaki GE et al. 2011 DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet. Med. 13, 913-920. (doi:10.1097/GIM.0b013e 3182368a0e)
37. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP. 2012 Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet. Gynecol. 119, 890-901. (doi:10.1097/AOG.0b013e31824fb482)
38. Chen EZ et al. 2011 Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS ONE 6, e21791. (doi:10.1371/journal.pone.0021791)
39. Sehnert AJ, Rhees B, Comstock D, de Feo E, Heilek G, Burke J, Rava RP 2011 Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin. Chem. 57, 1042-1049. (doi:10.1373/clinchem.2011.165910)
40. Lau TK et al. In press. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J. Matern. Fetal Neonatal Med. (doi:10.3109/14767058.2011.635730)
41. Palomaki GE et al. 2012 DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet. Med. 14, 296-305. (doi:10.1038/gim.2011.73)
42. van den Oever JM et al. 2012 Single molecule sequencing of free DNA from maternal plasma for noninvasive trisomy 21 detection. Clin. Chem. 58, 699-706. (doi:10.1373/clinchem.2011. 174698)
43. Liao GJ, Lun FMF, Zheng YWL, Chan KCA, Leung TY, Lau TK, Chiu RWK, Lo YMD. 2011 Targeted massively parallel sequencing of maternal plasma DNA permits efficient and unbiased detection of fetal alleles. Clin. Chem. 57, 92-101. (doi:10. 1373/clinchem.2010.154336)
44. Sparks AB et al. 2012 Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat. Diagn. 32, 3-9. (doi:10.1002/pd.2922)
45. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. 2012 Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 206, 319.e1-319.e9. (doi:10.1016/j.ajog.2012.01.030)
46. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH. 2012 Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am. J. Obstet. Gynecol. 206, 322.e1-322.e5. (doi:10.1016/j.ajog.2012.01.029)
47. Lun FMF et al. 2008 Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc. Natl Acad. Sci. USA 105, 19 920-19 925. (doi:10.1073/pnas. 0810373105)
48. Tsui NB et al. 2011 Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 117, 3684-3691. (doi:10.1182/blood-2010-10-310789)
49. Lo YMD et al. 2010 Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci. Transl. Med. 2, 61ra91. (doi:10.1126/scitranslmed.3001720)
50. Greely HT. 2011 Get ready for the flood of fetal gene screening. Nature 469, 289-291. (doi:10.1038/469289a)
51. de Jong A, Dondorp WJ, Frints SG, de Die-Smulders CE, de Wert GM. 2011 Advances in prenatal screening: the ethical dimension. Nat. Rev. Genet. 12, 657-663. (doi:10.1038/nrg3036)
52. Chitty LS, Hill M, White H, Wright D, Morris S. 2012 Noninvasive prenatal testing for aneuploidy-ready for prime time? Am. J. Obstet. Gynecol. 206, 269-275. (doi:10.1016/j.ajog.2012.02.021)